The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sorafenib versus sunitinib as first-line treatment in metastatic renal cell carcinoma: Largest multicenter retrospective analysis.
 
Xinan Sheng
No Relationships to Disclose
 
Hailiang Zhang
No Relationships to Disclose
 
Xuesong Li
No Relationships to Disclose
 
Zhihong Chi
No Relationships to Disclose
 
Zhisong He
No Relationships to Disclose
 
Dingwei Ye
No Relationships to Disclose
 
Jun Guo
No Relationships to Disclose